G20 Health Ministers Meeting Delivers Six Key Actions for the ... - 31 October 2022 19:33

BALI, Oct. 31, 2022 /PRNewswire-AsiaNet/ -- Indonesian Health Minister Budi Gunadi Sadikin closed G20 Second Health Ministerial Meeting in Bali, 28 October 2022. This meeting is the culmination of G20 discussions about strengthening the global health architecture and strengthening pandemic ...

  GenesisCare and PreludeDx(TM) present compelling Australian-fi... - 31 October 2022 08:00

California, Oct. 28, 2022/Medianet International-AsiaNet/ -- - GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDx(TM)), a leader in molecular diagnostics and precision medicine, today announced interim results from the AUSPREDICT registry. Data presented a...

  Unload Psoriatic Disease: World Psoriasis Day 2022 - 29 October 2022 16:00

STOCKHOLM, Oct. 29, 2022, /PRNewswire-AsiaNet/-- World Psoriasis Day is October 29th. Each year, the global psoriatic disease community unites for action to raise awareness of psoriatic disease. This year's theme is mental health. 1 in 10 people with psoriatic disease is diagnosed with clinic...

  World Stroke Organization Tackle Gaps in Access to Quality Str... - 29 October 2022 09:01

GENEVA, Oct. 28, 2022 /PRNewswire-AsiaNet/ - On World Stroke Day (29th Oct), the World Stroke Organization has announced the launch of a new program that aims to drive access to quality acute stroke care and save lives around the world. Logo - https://mma.prnewswire.com/media/1929364/Worl...

  Pharming Announces European Medicines Agency (EMA) Validates i... - 28 October 2022 16:00

LEIDEN, Netherlands, Oct. 28, 2022 /PRNewswire-AsiaNet/ -- -- Marketing authorisation in the European Economic Area anticipated in H1 2023 Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) announces today that its Marketing Authorisation Application (MAA) for ...

  Cambrex to Invest 16.5 Million USD in New R&D Facility in Minn... - 27 October 2022 21:00

EAST RUTHERFORD, N.J., Oct. 27, 2022 /PRNewswire-AsiaNet/ -- Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis–S...

  Texas Cardiac Arrhythmia Institute physician led international... - 27 October 2022 01:49

AUSTIN, Texas, Oct. 26, 2022 /PRNewswire-AsiaNet/ -- The executive medical director of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center ( https://c212.net/c/link/?t=0&l=en&o=3688951-1&h=30632352&u=https%3A%2F%2Ftcainstitute.com%2F&a=Texas+Cardiac+Arrhythmia+Institute+(TCAI...

  The future you desire. The life of your dreams. See it, feel i... - 27 October 2022 00:01

Sydney, Oct. 27, 2022/Medianet International-AsiaNet/ -- The first of its kind and totally unique – Lifeboard VR is a ground-breaking new manifestation platform to help users bring to reality their dreams and goals. It's time to enter a fully immersive virtual reality world where you can customize yo...

  OMRON Invests in Kirin Techno-System, Comprehensive Manufactur... - 26 October 2022 17:00

KYOTO, Japan, Oct. 26, 2022 /Kyodo JBN-AsiaNet/ -- - To Supply Safe and Secure Beverages and to Further Accelerate Global Environmental Conservation - OMRON Corporation (hereinafter "OMRON"), headquartered in Kyoto, and Kirin Brewery Company, Limited (hereinafter "Kirin Brewery"), a Tokyo-based...

  FDA Accepts NMP's Clinical Trial Application for Development o... - 25 October 2022 19:00

TOKYO, Oct. 25, 2022 /Kyodo JBN-AsiaNet/ -- - Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics - Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company in Japan, is pleased to announce that the U.S. Food and Drug Administration (FDA) has recently...